Sunnyvale and Mountain View, United States
DVS Sciences, Inc., a privately held innovator and manufacturer of novel
CyTOF® multi-parameter single-cell analyzers and reagents for biological
research, has announced a business agreement with Cytobank, Inc., a
privately held developer of cloud based scientific, informatics and
software solutions for the flow cytometry market.
The CyTOF mass cytometry platform developed by DVS Sciences enables
revolutionary understanding of cellular dynamics of disease states,
identification of stem cells and unprecedented insight into other
biological systems using metal conjugated antibodies bound to cells and
analyzed by time of flight mass spectrometry. The technology uniquely
has the capability to simultaneously measure up to 100 cell biomarkers
in single cells at up to 1000 cells per second. The software platform
created by Cytobank enables researchers to analyze and manage the data
acquired on CyTOF instruments using a novel cloud computing platform
integrated with proprietary algorithms for data analysis. Together, DVS
Sciences and Cytobank will co-develop and release an integrated
solution, “DVS Cytobank™”, that automatically analyzes and manages the
large data sets resulting from CyTOF instruments, while concurrently
providing information on reagent panels and protocols. The new venture
enables and simplifies the analysis of the massively multi-parameter
mass cytometry data. DVS Cytobank is a proprietary implementation
developed specifically for mass cytometry data, capitalizing on the
Cytobank platform and provided by DVS Sciences directly to researchers
using the CyTOF platform.
“The marriage of uniquely informative data acquired by our CyTOF
instruments and reagents with the powerful capabilities of the Cytobank
cloud based platform will be enabling for our researchers around the
world as they analyze, manage, and share large amounts of
multi-parameter data,” says Joseph Victor, President & CEO of DVS
Sciences. Nikesh Kotecha, Ph.D , CEO & Co-founder of Cytobank adds, “we
are excited to be partnering with DVS Sciences to create a software
solution that enables the next generation of high dimensional cytometry
and single cell systems biology brought about by the CyTOF instrument.”
An early access version of DVS Cytobank will be released to the
customers of DVS Sciences in August with a formal release available by
November, 2012. For more information about the DVS Cytobank product,
visit the site page at dvs.cytobank.org. For more information about DVS
Sciences and the CyTOF mass cytometry platform, please visit www.DVSsciences.com.
For more information about Cytobank, visit www.cytobankinc.com.
About DVS Sciences, Inc.
DVS Sciences, Inc. manufactures and globally distributes novel
bioanalytical solutions for use in biomarker discovery, biological
research and potential future use in clinical applications. The patented
multi-parameter technology comprises a high-throughput mass cytometer
for quantitative individual cell analysis, CyTOF, and a suite of
reagents, which include stable-isotope-tagged antibodies. The CyTOF
platform overcomes the limitations of conventional flow cytometry,
simplifies sample preparation and can simultaneously identify up to 100
biomarkers with high resolution and wide dynamic range. CyTOF systems
are installed in leading laboratories across the U.S., Canada, Europe
and Asia. DVS Sciences has its global headquarters and reagent kit
manufacturing in Sunnyvale, California with a R&D and instrument
manufacturing facility near Toronto, Canada and a sales/support office
in the UK.
About Cytobank, Inc.
Cytobank, Inc. develops, hosts, and supports cloud-computing software
applications tailored for bioscience researchers, collaborators, and
core labs using flow cytometry. Based in Mountain View, CA, in the heart
of Silicon Valley, Cytobank, Inc. was founded and is managed by
scientist-entrepreneurs from Stanford University with a unique blend of
expertise in flow cytometry, cell signaling networks, drug discovery,
informatics and software development. Cytobank software is used around
the world by thousands of academic and industrial researchers to manage,
share, and analyze their cytometry data.